Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 487.00
+14.00 (2.96%)
Sep 30, 2026, 4:08 PM HKT
HKG:6990 Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, HKG:6990 stock has a consensus rating of "Strong Buy" and an average price target of $619.67. The average 1-year stock price forecast is 27.24% higher than the current stock price, while the lowest is $520.00 (+6.78%) and the highest is $765.30 (+57.15%).
Price Target: $619.67 (+27.24%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:6990 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 15 | 15 | 15 | 16 | 17 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 18 | 18 | 18 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Buy Maintains $667.00 → $678.00 | Buy | Maintains | $667.00 → $678.00 | +39.22% | Sep 8, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $571.39 | Buy | Maintains | $571.39 | +17.33% | Aug 28, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $630.00 | Buy | Maintains | $630.00 | +29.36% | Aug 26, 2026 |
Unknown Analyst SPDB No rating | SPDB | Buy Maintains $611.60 → $624.00 | Buy | Maintains | $611.60 → $624.00 | +28.13% | Aug 21, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $642.00 | Buy | Maintains | $642.00 | +31.83% | Aug 20, 2026 |
Financial Forecast
Revenue This Year
2.54B
from 2.06B
Increased by 23.57%
Revenue Next Year
4.42B
from 2.54B
Increased by 73.92%
EPS This Year
0.68
from -0.89
EPS Next Year
2.98
from 0.68
Increased by 335.04%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.